LETTER TO THE EDITOR
COVID-19 infection in type 1 diabetes: emerging data
| 1 | Clinic of Endocrinology and Metabolism Diseases, Pordenone Hospital, Azienda Sanitaria Friuli Occidentale, Italy |
Submission date: 2021-01-11
Final revision date: 2021-02-08
Acceptance date: 2021-03-01
Publication date: 2021-04-06
Arch Med Sci Atheroscler Dis 2021;6(1):3–4
TOPICS
ABSTRACT
Type 2 diabetes mellitus is one of the most common comorbidities associated with COVID-19. Furthermore, people with type 2 diabetes infected with SARS-CoV-2 have higher hospitalization and mortality rates [1].
Most publications do not distinguish between type 1 and type 2 diabetes, so evidence relating to the spread of COVID-19 infection in type 1 diabetes is limited, but new data are emerging.
Most publications do not distinguish between type 1 and type 2 diabetes, so evidence relating to the spread of COVID-19 infection in type 1 diabetes is limited, but new data are emerging.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.